Thanks to a longtime Minnesota philanthropist and the State of Minnesota, neuroscience and diabetes researchers at the University of Minnesota and the Mayo Clinic are looking at millions in research grant funding from two new programs:
Rochester, Minnesota's Mayo Clinic plans to develop a $10 million outpatient cancer treatment center in Northfield, Minnesota. It will serve an estimated 200 million people.
Proton beam therapy is a form of targeted cancer treatment that has fewer debilitating side effects than traditional radiotherapy. The Mayo Clinic is a world-class center for cancer research and care in the Midwest, and now it will expand its holdings to include two new proton beam therapy centers, one in Rochester and another at its sister clinic in Phoenix. The type of advanced pencil beam scanning therapeutic equipment that the Mayo Clinic Proton Beam Therapy Center will use is very expensive (the two facilities will have a combined total cost of over $400M for 8 treatment rooms), and the $100 Million outright gift from philanthropist Richard O. Jacobson made earlier this year will go a considerable way toward advancing the project's progress.
Intensity-modulated proton beam therapy is less damaging to the cancer patient's healthy cells (surrounding the cancerous growth) because:
The State of Minnesota is funding 5 medical research studies to be carried out by the Partnership for Biotechnology and Medical Genomics, a collaborative between the state's largest medical research institutions: the University of Minnesota (Minneapolis) and the Mayo Clinic (Rochester). This latest round of 2-year grants totals $3.5 Million. If successful, the 5 projects will either produce results that qualify them for futher federal or private funding, or produce intellectual property that can be marketed.
The research projects focus on: